OncoSec ElectroImmunotherapy Shows Systemic Effects of Metastatic Melanoma Tumor in More than 50% of Patients Jun 07, 2011 6:01am EDT
OncoSec Medical Clinical Adviser Will Present ElectroImmunotherapy Results From Melanoma Clinical Trial at 2011 ASCO Annual Meeting Jun 02, 2011 6:01am EDT
OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals Apr 04, 2011 6:02am EDT
OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals Mar 15, 2011 4:01am EDT
